Literature DB >> 11100806

CD5 signal transduction: positive or negative modulation of antigen receptor signaling.

F Lozano1, M Simarro, J Calvo, J M Vilà, O Padilla, M A Bowen, K S Campbell.   

Abstract

The CD5 lymphocyte surface glycoprotein is a coreceptor involved in the modulation of antigen-specific receptor-mediated activation and differentiation signals. Although first considered a costimulatory molecule in mature peripheral T cells, recent studies of CD5-/- mice have opened the possibility that CD5 may also mediate inhibitory signals that attenuate TCR/CD3- and BCR-mediated triggering in thymocytes and a subgroup of B cells (B-1a cells), respectively. The ultimate molecular basis for these differential modulatory properties of CD5, depending on the context of lymphocyte subset and differentiation stage, are presently unknown and are an issue of current intensive investigation. Here, we review recent reports, both contradictory and complementary, focused on CD5-mediated molecular intracellular signaling events that could provide the basis for its immunomodulatory properties.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11100806

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  18 in total

Review 1.  CD5, an important regulator of lymphocyte selection and immune tolerance.

Authors:  Chander Raman
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Change of mouse CD5(+) B1 cells to a macrophage-like morphology induced by gamma interferon and inhibited by interleukin-4.

Authors:  Naoki Koide; Tsuyoshi Sugiyama; Isamu Mori; Mya Mya Mu; Teruaki Hamano; Tomoaki Yoshida; Takashi Yokochi
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling.

Authors:  Zilu Zhu; Ran Li; Hao Li; Tong Zhou; Randall S Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 4.  The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

Authors:  Gloria Soldevila; Chander Raman; Francisco Lozano
Journal:  Curr Opin Immunol       Date:  2011-04-07       Impact factor: 7.486

5.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

Review 6.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

7.  Evolution of the CD163 family and its relationship to the bovine gamma delta T cell co-receptor WC1.

Authors:  Carolyn T A Herzig; Ray W Waters; Cynthia L Baldwin; Janice C Telfer
Journal:  BMC Evol Biol       Date:  2010-06-15       Impact factor: 3.260

Review 8.  Antibody-based therapy of leukaemia.

Authors:  John C Morris; Thomas A Waldmann
Journal:  Expert Rev Mol Med       Date:  2009-09-30       Impact factor: 5.600

9.  CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock.

Authors:  Maria-Rosa Sarrias; Montserrat Farnós; Rubén Mota; Fernando Sánchez-Barbero; Anna Ibáñez; Idoia Gimferrer; Jorge Vera; Rafael Fenutría; Cristina Casals; José Yélamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-29       Impact factor: 11.205

10.  A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.

Authors:  Martina Bamberger; Ana Mafalda Santos; Carine M Gonçalves; Marta I Oliveira; John R James; Alexandra Moreira; Franscisco Lozano; Simon J Davis; Alexandre M Carmo
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.